Learn about the latest advancements in immunotherapy research focusing on harnessing IL-12 for the treatment of ovarian cancer to potentially improve survival rates.

Cancer Gene Therapy - Intratumoral injection of IL-12 plasmid DNA – results of a phase I/IB clinical trial Skip to main content Thank you for visiting nature.com.

Investigators from Brigham and Women’s Hospital and Dana-Farber Cancer Institute found that combining Ziopharm’s small-molecule oral drug veledimex with an IL-12 gene therapy was safe in an ...

Background: We investigated whether immune system impairment manifested by increased Interleukin-10 (IL-10) and reduced IL-12 levels occur in breast cancer patients and determined the effect of ...

A team of Rice University bioengineers has developed a mathematical model that clarifies why interleukin-12 (IL-12) ⎯ a potent immune-boosting protein that holds promise for cancer treatment ...

By sparking the immune system into action, radiation therapy makes certain tumors that resist immunotherapy susceptible to ...

This study reveals the potential of engineered phage-IL-12 therapy in melanoma, enhancing immune response and tumor destruction in aggressive cancer models.

The hot flashes and night sweats that plague breast cancer survivors during years-long hormone-suppressing therapy are eased ...